← Back to Kilitch Drugs India Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

KILITCHPharmaceuticals

Kilitch Drugs India Ltd — Financial Ratios & Key Metrics

₹124.45

-9.06%

P/E Ratio21.74xIndustry: 31.77x

ROE12.61%Return on equity

ROCE15.67%Return on capital

Debt/Equity0.31Low debt

💎

Valuation & Profitability

P/E Ratio

21.74x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹599.59 (Cr)

Sales Growth 5Y

30.06%

Profit Growth 5Y

158.61%

EPS Growth 5Y

156.54%

OPM 5Y Avg

13.27%

📉

Price Returns

1 Month

-11.47%

3 Months

-2.33%

6 Months

-16.75%

1 Year

+11.32%

52W Low

₹137

Current

₹124

52W High

₹500

-3% of 52-week range — Near lows

🔬

Technical Indicators

Oversold

Selling pressure is heavy — potential reversal zone.

SMA 50

₹316

▼ Price below SMA 50 — Bearish

SMA 200

₹368

▼ Long-term downtrend

Volume Signal

291% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Kilitch Drugs India Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.